LAP3 and hepatocellular carcinoma: In conclusion, 2D-TPP of the analog compounds PCI-3405 and BRD-3811 and DLPTP analysis revealed their intracellular target space (Supplementary Data 2) and showed that both bind and inhibit LAP3, a potentially interesting ovarian cancer and hepatocellular carcinoma target.